WASHINGTON TRUST Co - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 915 filers reported holding BAXTER INTL INC in Q4 2013. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
WASHINGTON TRUST Co ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$47,364
-38.6%
1,255
-25.9%
0.00%
-33.3%
Q2 2023$77,179
+9.5%
1,694
-2.5%
0.00%0.0%
Q1 2023$70,494
-15.9%
1,738
+5.7%
0.00%
-25.0%
Q4 2022$83,794
-13.6%
1,644
-9.0%
0.00%
-20.0%
Q3 2022$97,000
-14.2%
1,806
+2.8%
0.01%0.0%
Q2 2022$113,000
-18.1%
1,756
-0.8%
0.01%0.0%
Q1 2022$138,000
-54.9%
1,771
-50.4%
0.01%
-16.7%
Q4 2021$306,000
+146.8%
3,570
+130.5%
0.01%
+100.0%
Q3 2021$124,0000.0%1,5490.0%0.00%0.0%
Q2 2021$124,000
-5.3%
1,5490.0%0.00%
-25.0%
Q1 2021$131,000
-24.7%
1,549
-28.7%
0.00%
-33.3%
Q4 2020$174,000
+48.7%
2,174
+48.7%
0.01%
+50.0%
Q3 2020$117,000
-12.7%
1,462
-7.6%
0.00%
-33.3%
Q2 2020$134,000
-0.7%
1,582
-4.5%
0.01%0.0%
Q1 2020$135,000
+4.7%
1,657
-5.2%
0.01%
-14.3%
Q2 2018$129,000
-62.4%
1,747
-77.0%
0.01%
-69.6%
Q2 2016$343,000
+0.3%
7,586
-8.9%
0.02%0.0%
Q1 2016$342,000
+7.2%
8,331
-0.5%
0.02%
+4.5%
Q4 2015$319,000
+8.9%
8,371
-6.2%
0.02%
+4.8%
Q3 2015$293,000
-49.9%
8,921
+6.8%
0.02%
-46.2%
Q2 2015$585,000
-27.1%
8,356
-28.7%
0.04%
-26.4%
Q1 2015$803,000
-87.7%
11,719
-86.9%
0.05%
-88.2%
Q4 2014$6,536,000
+4.9%
89,170
+2.7%
0.45%
-1.8%
Q3 2014$6,229,000
+9.1%
86,793
+9.9%
0.46%
+9.3%
Q2 2014$5,710,000
+1.5%
78,964
+3.3%
0.42%
-1.2%
Q1 2014$5,623,000
+13.0%
76,433
+6.8%
0.42%
+11.6%
Q4 2013$4,975,000
+10.9%
71,544
+4.7%
0.38%
+5.3%
Q3 2013$4,487,000
+9.3%
68,311
+15.3%
0.36%
+4.0%
Q2 2013$4,104,00059,2360.35%
Other shareholders
BAXTER INTL INC shareholders Q4 2013
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders